Caggiano V - Search Results

1

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.

Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Bauer KR, et al. Among authors: caggiano v. Cancer. 2007 May 1;109(9):1721-8. doi: 10.1002/cncr.22618. Cancer. 2007. PMID: 17387718 Free article.

2

Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy.

Caggiano V, Weiss RV, Rickert TS, Linde-Zwirble WT. Caggiano V, et al. Cancer. 2005 May 1;103(9):1916-24. doi: 10.1002/cncr.20983. Cancer. 2005. PMID: 15751024 Free article.

3

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.

Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V. Brown M, et al. Among authors: caggiano v. Cancer. 2008 Feb 15;112(4):737-47. doi: 10.1002/cncr.23243. Cancer. 2008. PMID: 18189290 Free article.

4

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.

Parise CA, Bauer KR, Brown MM, Caggiano V. Parise CA, et al. Among authors: caggiano v. Breast J. 2009 Nov-Dec;15(6):593-602. doi: 10.1111/j.1524-4741.2009.00822.x. Epub 2009 Sep 17. Breast J. 2009. PMID: 19764994

5

Variation in breast cancer subtypes with age and race/ethnicity.

Parise CA, Bauer KR, Caggiano V. Parise CA, et al. Among authors: caggiano v. Crit Rev Oncol Hematol. 2010 Oct;76(1):44-52. doi: 10.1016/j.critrevonc.2009.09.002. Epub 2009 Oct 2. Crit Rev Oncol Hematol. 2010. PMID: 19800812

6

Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer.

Bauer K, Parise C, Caggiano V. Bauer K, et al. Among authors: caggiano v. BMC Cancer. 2010 May 21;10:228. doi: 10.1186/1471-2407-10-228. BMC Cancer. 2010. PMID: 20492696 Free PMC article.

7

Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California.

Parise CA, Bauer KR, Caggiano V. Parise CA, et al. Among authors: caggiano v. Cancer. 2012 May 1;118(9):2516-24. doi: 10.1002/cncr.26542. Epub 2011 Sep 14. Cancer. 2012. PMID: 21918967 Free article.

8

Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.

Parise CA, Caggiano V. Parise CA, et al. Among authors: caggiano v. BMC Cancer. 2013 Oct 2;13:449. doi: 10.1186/1471-2407-13-449. BMC Cancer. 2013. PMID: 24083624 Free PMC article.

9

Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.

Parise CA, Caggiano V. Parise CA, et al. Among authors: caggiano v. J Cancer Epidemiol. 2014;2014:469251. doi: 10.1155/2014/469251. Epub 2014 May 26. J Cancer Epidemiol. 2014. PMID: 24955090 Free PMC article.

10

Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.

Parise C, Caggiano V. Parise C, et al. Among authors: caggiano v. Cancer Epidemiol. 2014 Oct;38(5):556-62. doi: 10.1016/j.canep.2014.08.001. Epub 2014 Sep 22. Cancer Epidemiol. 2014. PMID: 25172158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page